Chia-Yi Hsu Selected Research

butylbenzyl phthalate (benzyl butyl phthalate)

8/2014	Benzyl butyl phthalate induces migration, invasion, and angiogenesis of Huh7 hepatocellular carcinoma cells through nongenomic AhR/G-protein signaling.
8/2012	Phthalates stimulate the epithelial to mesenchymal transition through an HDAC6-dependent mechanism in human breast epithelial stem cells.
2/2012	Phthalates induce proliferation and invasiveness of estrogen receptor-negative breast cancer through the AhR/HDAC6/c-Myc signaling pathway.
1/2012	n-Butyl benzyl phthalate promotes breast cancer progression by inducing expression of lymphoid enhancer factor 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chia-Yi Hsu Research Topics

Disease

14	Neoplasms (Cancer) 05/2022 - 01/2012
9	Breast Neoplasms (Breast Cancer) 05/2022 - 01/2012
6	Carcinogenesis 01/2019 - 02/2012
5	Endometriosis 01/2021 - 09/2011
4	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2012
3	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 12/2015 - 08/2014
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Stomach Neoplasms (Stomach Cancer) 12/2020
1	Infections 12/2020
1	Pathologic Neovascularization 12/2019
1	Carcinosarcoma 01/2017
1	Body Weight (Weight, Body) 01/2016
1	Inflammation (Inflammations) 12/2015
1	Neuroblastoma 12/2009

Drug/Important Bio-Agent (IBA)

6	phthalic acid (phthalate)IBA 12/2015 - 01/2012
5	MicroRNAs (MicroRNA)IBA 12/2018 - 02/2014
4	Hormones (Hormone)IBA 03/2016 - 01/2012
4	butylbenzyl phthalate (benzyl butyl phthalate)IBA 08/2014 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 05/2022 - 01/2021
3	4-boronic acid benzophenoneIBA 08/2014 - 01/2012
2	Estrogen ReceptorsIBA 01/2022 - 02/2012
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2015
2	Tumor Biomarkers (Tumor Markers)IBA 12/2020 - 01/2015
2	Complementary DNA (cDNA)IBA 10/2020 - 01/2012
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2019 - 08/2012
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 08/2014 - 07/2012
2	Dibutyl Phthalate (Butyl Phthalate)IBA 08/2012 - 02/2012
1	LuteolinIBA 05/2022
1	mono-(2-ethylhexyl)phthalateIBA 01/2022
1	2-methyl-5,6-cyclopentapyrimidineIBA 01/2022
1	venetoclaxIBA 01/2022
1	Diethylhexyl Phthalate (DEHP)IBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Lysine (L-Lysine)FDA Link 10/2020
1	NucleotidesIBA 10/2020
1	Interleukin-6 (Interleukin 6)IBA 10/2020
1	Interleukin-10 (Interleukin 10)IBA 12/2019
1	Interleukin-10 ReceptorsIBA 12/2019
1	3' Untranslated Regions (3' UTR)IBA 12/2018
1	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2018
1	Biological ProductsIBA 01/2017
1	SteroidsIBA 03/2016
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 03/2016
1	Danazol (Azol)FDA LinkGeneric 03/2016
1	Progesterone FDA LinkGeneric 03/2016
1	Cell-Penetrating PeptidesIBA 01/2016
1	Peptides (Polypeptides)IBA 01/2016
1	CateninsIBA 01/2016
1	AntidotesIBA 12/2015
1	CurcuminIBA 12/2015
1	Histone Deacetylase InhibitorsIBA 04/2015
1	GTP-Binding Proteins (G-Protein)IBA 08/2014
1	PlasticizersIBA 08/2014
1	Histone Deacetylase 6IBA 08/2012
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2012
1	CarcinogensIBA 07/2012
1	EstersIBA 02/2012
1	Estrogens (Estrogen)FDA Link 02/2012
1	Lymphoid Enhancer-Binding Factor 1IBA 01/2012
1	Small Interfering RNA (siRNA)IBA 01/2012
1	Messenger RNA (mRNA)IBA 01/2012
1	TCF Transcription FactorsIBA 01/2012
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2011
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2009

Therapy/Procedure

3	Therapeutics 01/2022 - 02/2014
2	Drug Therapy (Chemotherapy) 01/2022 - 04/2015
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2022
1	Heterologous Transplantation (Xenotransplantation) 01/2016
1	Immunomodulation 12/2015